FDA cleared the FAQ™ (FAQ 401);FAQ™ (FAQ 402) from Foreo, Inc. on Oct 26, 2026 under K261625, a traditional 510(k). The device falls under product code NFO, Stimulator, Transcutaneous Electrical, Aesthetic Purposes, regulated at 21 CFR 882.5890 as a Class 2 device. The review panel was Neurology.

FDA logged the submission as received on May 15, 2026. The decision came 164 days later, longer than the 90 FDA-day review goal, which usually means at least one additional information request.

Foreo, Inc. has 2 other decisions in the tracker over the last 12 months: K261565 (FAQ™ (FAQ 411)), K253683 (FAQ™ (LED Panel); FAQ™ (Dual LED Panel)).